Galectin Therapeutics (GALT) Prepaid Assets (2010 - 2026)
Galectin Therapeutics (GALT) recorded quarterly Prepaid Assets of $1.6 million in Q1 2026, down 7.93% quarter-over-quarter from $1.7 million in Q4 2025, and down 14.78% on a YoY basis from $1.9 million in Q1 2025.
Galectin Therapeutics (GALT) Prepaid Assets (2010 - 2026) Analysis & Trends
Galectin Therapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Prepaid Assets fell 14.78% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (down 14.78% YoY), while the FY2025 annual figure was $1.7 million, down 19.51% from the prior year.
- Prepaid Assets was $1.6 million for Q1 2026 at Galectin Therapeutics, down from $1.7 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $2.1 million in Q4 2024 to a low of $1.2 million in Q3 2025.
- Historically, Prepaid Assets has averaged $1.7 million across 5 years, with a median of $1.7 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Prepaid Assets advanced 28.58% in 2024, then dropped 25.03% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $2.0 million in 2022, then grew by 4.59% to $2.0 million in 2023, then climbed by 4.0% to $2.1 million in 2024, then retreated by 19.51% to $1.7 million in 2025, then dropped by 7.93% to $1.6 million in 2026.
- The last three Prepaid Assets figures came in at $1.6 million (Q1 2026), $1.7 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Galectin Therapeutics | 185.83 Mn | 171.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.58 Mn |
| Dec 31, 2025 | 1.72 Mn |
| Sep 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 1.66 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 2.13 Mn |
| Sep 30, 2024 | 1.61 Mn |
| Jun 30, 2024 | 1.69 Mn |
| Mar 31, 2024 | 1.91 Mn |
| Dec 31, 2023 | 2.05 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 1.50 Mn |
| Mar 31, 2023 | 1.75 Mn |
| Dec 31, 2022 | 1.96 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 1.61 Mn |
| Mar 31, 2022 | 1.90 Mn |
| Dec 31, 2021 | 2.17 Mn |
| Sep 30, 2021 | 1.40 Mn |
| Jun 30, 2021 | 1.74 Mn |